SOUTH SAN FRANCISCO - Pliant Therapeutics, Inc. (NASDAQ: PLRX), a biotechnology company focused on fibrotic diseases with a market capitalization of $674 million, has named Delphine Imbert, Ph.D., as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback